Activated leukocyte cell adhesion molecule (ALCAM or CD166) modulates bone phenotype and hematopoiesis

R. A. Hooker, B. R. Chitteti, P. H. Egan, Y. H. Cheng, E. R. Himes, T. Meijome, Edward Srour, Robyn K. Fuchs, Melissa Kacena

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166), is expressed on osteoblasts (OB) and hematopoietic stem cells (HSC) residing in the hematopoietic niche, and may have important regulatory roles in bone formation. Because HSC numbers are reduced 77% in CD166-/- mice, we hypothesized that changes in bone phenotype and consequently the endosteal niche may partially be responsible for this alteration. Therefore, we investigated bone phenotype and OB function in CD166-/-mice. Although osteoclastic measures were not affected by loss of CD166, CD166-/- mice exhibited a modest increase in trabecular bone fraction (42%), and increases in osteoid deposition (72%), OB number (60%), and bone formation rate (152%). Cortical bone geometry was altered in CD166-/-mice resulting in up to 81% and 49% increases in stiffness and ultimate force, respectively. CD166-/- OB displayed elevated alkaline phosphatase (ALP) activity and mineralization, and increased mRNA expression of Fra 1, ALP, and osteocalcin. Overall, CD166-/- mice displayed modestly elevated trabecular bone volume fraction with increased OB numbers and deposition of osteoid, and increased OB differentiation in vitro, possibly suggesting more mature OB are secreting more osteoid. This may explain the decline in HSC number in vivo because immature OB are mainly responsible for hematopoiesis enhancing activity.

Original languageEnglish
Pages (from-to)83-94
Number of pages12
JournalJournal of Musculoskeletal Neuronal Interactions
Volume15
Issue number1
StatePublished - 2015

Fingerprint

Activated-Leukocyte Cell Adhesion Molecule
Hematopoiesis
Osteoblasts
Phenotype
Bone and Bones
Hematopoietic Stem Cells
Osteogenesis
Alkaline Phosphatase
Cell Count
Osteocalcin

Keywords

  • ALCAM
  • Bone mass
  • Bone microenvironment
  • Bone structure
  • CD166
  • Hematopoiesis
  • Osteoblasts

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine
  • Physiology

Cite this

Hooker, R. A., Chitteti, B. R., Egan, P. H., Cheng, Y. H., Himes, E. R., Meijome, T., ... Kacena, M. (2015). Activated leukocyte cell adhesion molecule (ALCAM or CD166) modulates bone phenotype and hematopoiesis. Journal of Musculoskeletal Neuronal Interactions, 15(1), 83-94.

Activated leukocyte cell adhesion molecule (ALCAM or CD166) modulates bone phenotype and hematopoiesis. / Hooker, R. A.; Chitteti, B. R.; Egan, P. H.; Cheng, Y. H.; Himes, E. R.; Meijome, T.; Srour, Edward; Fuchs, Robyn K.; Kacena, Melissa.

In: Journal of Musculoskeletal Neuronal Interactions, Vol. 15, No. 1, 2015, p. 83-94.

Research output: Contribution to journalArticle

Hooker, RA, Chitteti, BR, Egan, PH, Cheng, YH, Himes, ER, Meijome, T, Srour, E, Fuchs, RK & Kacena, M 2015, 'Activated leukocyte cell adhesion molecule (ALCAM or CD166) modulates bone phenotype and hematopoiesis', Journal of Musculoskeletal Neuronal Interactions, vol. 15, no. 1, pp. 83-94.
Hooker, R. A. ; Chitteti, B. R. ; Egan, P. H. ; Cheng, Y. H. ; Himes, E. R. ; Meijome, T. ; Srour, Edward ; Fuchs, Robyn K. ; Kacena, Melissa. / Activated leukocyte cell adhesion molecule (ALCAM or CD166) modulates bone phenotype and hematopoiesis. In: Journal of Musculoskeletal Neuronal Interactions. 2015 ; Vol. 15, No. 1. pp. 83-94.
@article{85e0e61f0040451db529011bcaeaece5,
title = "Activated leukocyte cell adhesion molecule (ALCAM or CD166) modulates bone phenotype and hematopoiesis",
abstract = "Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166), is expressed on osteoblasts (OB) and hematopoietic stem cells (HSC) residing in the hematopoietic niche, and may have important regulatory roles in bone formation. Because HSC numbers are reduced 77{\%} in CD166-/- mice, we hypothesized that changes in bone phenotype and consequently the endosteal niche may partially be responsible for this alteration. Therefore, we investigated bone phenotype and OB function in CD166-/-mice. Although osteoclastic measures were not affected by loss of CD166, CD166-/- mice exhibited a modest increase in trabecular bone fraction (42{\%}), and increases in osteoid deposition (72{\%}), OB number (60{\%}), and bone formation rate (152{\%}). Cortical bone geometry was altered in CD166-/-mice resulting in up to 81{\%} and 49{\%} increases in stiffness and ultimate force, respectively. CD166-/- OB displayed elevated alkaline phosphatase (ALP) activity and mineralization, and increased mRNA expression of Fra 1, ALP, and osteocalcin. Overall, CD166-/- mice displayed modestly elevated trabecular bone volume fraction with increased OB numbers and deposition of osteoid, and increased OB differentiation in vitro, possibly suggesting more mature OB are secreting more osteoid. This may explain the decline in HSC number in vivo because immature OB are mainly responsible for hematopoiesis enhancing activity.",
keywords = "ALCAM, Bone mass, Bone microenvironment, Bone structure, CD166, Hematopoiesis, Osteoblasts",
author = "Hooker, {R. A.} and Chitteti, {B. R.} and Egan, {P. H.} and Cheng, {Y. H.} and Himes, {E. R.} and T. Meijome and Edward Srour and Fuchs, {Robyn K.} and Melissa Kacena",
year = "2015",
language = "English",
volume = "15",
pages = "83--94",
journal = "Journal of Musculoskeletal Neuronal Interactions",
issn = "1108-7161",
publisher = "International Society of Musculoskeletal and Neuronal Interactions",
number = "1",

}

TY - JOUR

T1 - Activated leukocyte cell adhesion molecule (ALCAM or CD166) modulates bone phenotype and hematopoiesis

AU - Hooker, R. A.

AU - Chitteti, B. R.

AU - Egan, P. H.

AU - Cheng, Y. H.

AU - Himes, E. R.

AU - Meijome, T.

AU - Srour, Edward

AU - Fuchs, Robyn K.

AU - Kacena, Melissa

PY - 2015

Y1 - 2015

N2 - Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166), is expressed on osteoblasts (OB) and hematopoietic stem cells (HSC) residing in the hematopoietic niche, and may have important regulatory roles in bone formation. Because HSC numbers are reduced 77% in CD166-/- mice, we hypothesized that changes in bone phenotype and consequently the endosteal niche may partially be responsible for this alteration. Therefore, we investigated bone phenotype and OB function in CD166-/-mice. Although osteoclastic measures were not affected by loss of CD166, CD166-/- mice exhibited a modest increase in trabecular bone fraction (42%), and increases in osteoid deposition (72%), OB number (60%), and bone formation rate (152%). Cortical bone geometry was altered in CD166-/-mice resulting in up to 81% and 49% increases in stiffness and ultimate force, respectively. CD166-/- OB displayed elevated alkaline phosphatase (ALP) activity and mineralization, and increased mRNA expression of Fra 1, ALP, and osteocalcin. Overall, CD166-/- mice displayed modestly elevated trabecular bone volume fraction with increased OB numbers and deposition of osteoid, and increased OB differentiation in vitro, possibly suggesting more mature OB are secreting more osteoid. This may explain the decline in HSC number in vivo because immature OB are mainly responsible for hematopoiesis enhancing activity.

AB - Activated Leukocyte Cell Adhesion Molecule (ALCAM/CD166), is expressed on osteoblasts (OB) and hematopoietic stem cells (HSC) residing in the hematopoietic niche, and may have important regulatory roles in bone formation. Because HSC numbers are reduced 77% in CD166-/- mice, we hypothesized that changes in bone phenotype and consequently the endosteal niche may partially be responsible for this alteration. Therefore, we investigated bone phenotype and OB function in CD166-/-mice. Although osteoclastic measures were not affected by loss of CD166, CD166-/- mice exhibited a modest increase in trabecular bone fraction (42%), and increases in osteoid deposition (72%), OB number (60%), and bone formation rate (152%). Cortical bone geometry was altered in CD166-/-mice resulting in up to 81% and 49% increases in stiffness and ultimate force, respectively. CD166-/- OB displayed elevated alkaline phosphatase (ALP) activity and mineralization, and increased mRNA expression of Fra 1, ALP, and osteocalcin. Overall, CD166-/- mice displayed modestly elevated trabecular bone volume fraction with increased OB numbers and deposition of osteoid, and increased OB differentiation in vitro, possibly suggesting more mature OB are secreting more osteoid. This may explain the decline in HSC number in vivo because immature OB are mainly responsible for hematopoiesis enhancing activity.

KW - ALCAM

KW - Bone mass

KW - Bone microenvironment

KW - Bone structure

KW - CD166

KW - Hematopoiesis

KW - Osteoblasts

UR - http://www.scopus.com/inward/record.url?scp=84923913758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923913758&partnerID=8YFLogxK

M3 - Article

C2 - 25730656

AN - SCOPUS:84923913758

VL - 15

SP - 83

EP - 94

JO - Journal of Musculoskeletal Neuronal Interactions

JF - Journal of Musculoskeletal Neuronal Interactions

SN - 1108-7161

IS - 1

ER -